Pathogenesis of the antiphospholipid antibody syndrome

Lupus

Volumn 5, Issue 5, 1996, Pages 404-408

  Lockshin, M D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antiphospholipid antibody; Endothelium; Placenta; Platelets; 2 glycoprotein I

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

EID: 0029837083     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500514     Document Type: Conference Paper

References (43)

1. Vargas-Alarcon G et al. Association of HLA-DR5 (possibly DDRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis Rheum 1995; 38: 1340-1343.
2. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Amer J Med 1995; 99: 473-479.
3. Camps MT et al. Association between HLA class II antigens in primary antiphospholipid syndrome from the south of Spain. Lupus 1995; 4. 51-55.
4. Demaison C et al. Analysis of variable region genes encoding anti-Sm and anticardiolipin antibodies from a systemic lupus erythematosus patient. Immunol 1995;86: 487-494.
5. Harmer IJ et al. A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded. Arthritis Rheum 1995; 38: 1068-1076.
6. 2-glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J Immunol 1996; 156: 2631-2641.
7. Hohmann et al. Immunoglobulin gene sequence-analysis of anticardiolipin and anticardiolipin idiotype (H3) human monoclonal-antibodies. Autoimmunity 1995; 22: 49-57.
8. Meroni PI et al. Antiphospholipid antibodies and endothelial cells: an unending story. Lupus 1995; 4: 169-171.
9. 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus 1995; 4: 179-186.
10. Vaaraala O, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91: 23-27.
11. Simantov R et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
12. 2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179-185.
13. Casiola-Rosen L et al. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity-implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996; 93: 1624-1629.
14. Nakamura N et al. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. Biochem Biophys Res Commun 1994; 205: 1488-1493.
15. Pierangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 1994; 3: 247-251.
16. Barquinero J et al. Antibodies against platelet-activating factor in patients with antiphospholipid antibodies. Lupus 1994; 3: 55-58.
17. Vazquez-Mellado J et al Exposure of anionic phospholipids upon platelet activation permits binding of beta-2 glycoprotein I and through it that of IgG antiphospholipid antibodies - studies in platelets from patients with antiphospholipid antibody syndrome and normal subjects. J Autoimmun 1994; 7: 335-348.
18. Tokita S et al. Specific cross-reaction of IgG antiphospholipid antibody with platelet glycoprotein IIIA. Thromb Haemostasis 1996; 75: 168-174
19. Campbell AL et al. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 1995; 73: 529-534.
20. Font J et al. Effect of human monoclonal antiphospholipid antibodies in platelet interaction with a collagen rich surface under flow conditions. Arthritis Rheum 1995; 38: s277 (abstract).
21. Dizon-Townson D et al. The factor V Leiden mutation which predisposes to thrombosis is not common in patients wtih antiphospholipid syndrome. Thromb Haemost 1995; 74: 1029-1031.
22. Mori T et al. Beta(2)-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemost 1996; 75: 49-55.
23. Esmon CT Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB Jour 1995; 9: 946-955.
24. Merrill JT, Lahita RG. Hypothesis: The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?. Lupus 1996; 5: 6-10.
25. Tomer Y, Blank M, Shoenfeld Y. Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies. Arthritis Rheum 1994; 37: 1236-1244.
26. Branch DW. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994; 3: 275-280.
27. Sammaritano L et al. A prospective study of clinical features and placental pathology in systemic lupus erythematosus (SLE) with and without antiphospholipid antibodies. Arthritis Rheum 1995; 38: s218 (abstract).
28. Nayar R, Lage JM. Placental changes in a first-trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome - a case report and review of the literature. Human Pathol 1996; 27: 201-206.
29. Sammaritano LR et al. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J Clin Immunol 1992; 12: 27-35.
30. La Rosa L et al. Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994; 21: 1684-1693.
31. Katano K et al. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera. Lupus 1995; 4: 304-308.
32. Gharavi AE, Wilson WA. Mouse models for the antiphospholipid syndrome Lupus 1993; 2. 289-290.
33. Fishman P et al. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo admininstration of recombinant interleukin-3. J Clin Invest 1993; 91: 1834-1837.
34. Suzuki T et al. Effects of monoclonal anticardiolipin antibody on pregnant mice. J Rheumatol 1996; 23. 83-86.
35. Silver RM et al. Induction of high levels of anticardiolipin antibodies in mice by immunization with beta(2)-glycoprotein-I does not cause fetal death. Amer J Obstet and Gynecol 1995; 173: 1410-1415.
36. Peaceman AM, Rehnberg KA. The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with iminunoglobulin G fractions from patients with lupus anticoagulants. Amer J Obstet Gynecol 1995; 173: 1391-1396.
37. Fishman P et al. Aspirin-interleukin 3 interrelationships in patients with antiphospholipid syndrome. Amer J Reprod Immunol 1996; 35: 80-84.
38. Fishman P et al. Aspirin modulates interleukin-3 production: additional explanation for the preventive effects of aspirin in antiphospholipid syndrome. J Rheumatol 1995; 22: 1086-1090.
39. Krause I et al. The effect of aspirin on recurrent fetal loss in experimental anti-phospholipid syndrome. Am J Reprod Immunol 1993; 29: 155-161.
40. Inbar O et al. Prevention of fetal loss in experimental antiphospholipid syndrome by low molecular weight heparin. Am J Obstet Gynecol 1993; 169: 423-426.
41. Adler RR, Ng AK, Rote NS. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53: 905-510.
42. Di Simone N et al. In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin-releasing hormone-dependent human chorionic gonadotrophin release by cultured trophoblast cells. Placenta 1995; 16: 75-83.
43. Vogt E, Ng AK, Rote NS. A model for antiphospholipid antibody syndrome - monoclonal antiphosphotidylserine antibody induces intrauterine growth restriction in mice. Amer J Obstet Gynecol 1996; 174: 700-707.